Recent Advances in the Diagnosis and Management of Congenital Heart Disease

P. Syamasundar Rao

DOI: https://doi.org/10.3390/children11010084

2024-01-11

Children

Abstract:Congenital heart defects (CHDs) are structural abnormalities of the heart or blood vessels that occur while cardiac structures are being formed in utero [...]

pediatrics

What problem does this paper attempt to address?

The Progress and Challenges of Surgical Treatment for Congenital Heart Disease

张泽伟

DOI: https://doi.org/10.3760/cma.j.issn.1008-1372.2014.08.001

2014-01-01

Abstract:Congenital heart disease is one of the highest incidence of birth defects .With the progress of the diagnosis and treat-ment ,most of the children got accurate diagnosis and treatment .The treatment of congenital heart disease focus on minimally invasive for simple congenital heart disease ,and early diagnosis and early treatment for complex heart disease ( especially the progress of the neo-natal cardiac surgery ) ,and hybrid procedure in complex heart disease .
ADVANCES IN DIAGNOSIS AND TREATMENT OF CONGENITAL HEART DISEASE: A COMPREHENSIVE REVIEW

Jan Ramian,Karol Wielgus,Maria Pawłowska,Piotr Bator,Grzegorz Łyko,Karol Magiera Magiera,Maria Antos,Adrian Bobrzyk,Angelika Wawryszuk,Weronika Kamińska

DOI: https://doi.org/10.35630/2024/14/4.407

2024-09-03

Archiv Euromedica

Abstract:The purpose of this article is to provide a comprehensive review of recent advances in the diagnosis and treatment of congenital heart disease (CHD). CHD, which affects about 1% of live births worldwide, is still a major problem in pediatric cardiology. The most prevalent congenital cardiac defects—Ventricular Septal Defect (VSD), Tetralogy of Fallot (TOF), Coronary Artery Fistula, Coarctation of the Aorta (CoA), Aortic and Pulmonary Stenosis, Valve Insufficiency, Double Outlet Right Ventricle (DORV), Ebstein Anomaly, Transposition of the Great Arteries (TGA), Anomalous Venous Return, and Hypoplastic Left Heart Syndrome (HLHS) are all thoroughly examined in this review. The review examines current diagnostic and treatment strategies, highlighting the benefits, drawbacks, sensitivity, and specificity of several imaging modalities, including as CT, MRI, and echocardiography. It also discusses the historical evolution of treatment outcomes, emphasizing the tremendous advances in patient care and surgical procedures that have significantly mproved survival rates and quality of life for CHD patients.
The Current Strategy in Managing Congenital and Structural Heart Disease: Find and Treat Them Appropriately

Radityo Prakoso

DOI: https://doi.org/10.21776/ub/hsj.2024.005.02.2

2024-04-28

Heart Science Journal

Abstract:Significant progress has been made in diagnosing and treating congenital heart defects (CHDs) over the past five decades. Notable advancements include pulse oximetry screening for critical CHDs in newborns and percutaneous, catheter-based procedures, improving outcomes even in developing nations. Recent studies demonstrate favorable outcomes with device closure of acyanotic CHDs, with non-fluoroscopy techniques adopted to minimize radiation risks. Positive results are observed with right ventricular outflow tract (RVOT) stent palliation for late-presenting cyanotic congenital heart diseases such as tetralogy of Fallot (TOF). Novel interventions like reverse Potts shunt anastomosis show promise in managing pediatric pulmonary arterial hypertension (PAH), while prophylactic treatments effectively reduce postoperative arrhythmias. Fontan procedure significantly enhances survival rates for individuals with single functional ventricles, although challenges arise with aging populations. In developed countries, fetal cardiac interventions utilizing advanced imaging techniques allow for early detection and preventive interventions, reducing secondary complications. Keyword: Fetal Intervention, Fontan, Non-Fluoroscopy, Percutaneous, Reverse Potts, Rheumatic Heart Disease, RVOT Stenting.
[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Guangfeng Tian,Hui Gao,Shasha Hu,Qiang Shu

DOI: https://doi.org/10.3785/j.issn.1008-9292.2018.06.02

2018-01-01

Abstract:Congenital heart disease (CHD) is a type of birth defects due to the abnormal development of heart and blood vessels during embryonic stage. Studies indicate that the etiology of CHD is complicated. Genetic and epigenetic mechanisms including chromosomal abnormalities, gene mutations, nucleic acid modifications, non-coding RNAs may play important roles in CHD. At present, genetic mechanisms such as chromosome abnormality and gene mutation have been widely used in the diagnosis and treatment of clinical diseases. However, the application of genetic and epigenetic modification in diagnosis and treatment of CHD still need further research. This paper reviews the relationship between chromosomal abnormality, gene mutation, copy number variation, epigenetic modification and the occurrence of CHD, which may provide a basis for further exploring the early diagnosis and individualized therapy of CHD.
Congenital heart disease: types, pathophysiology, diagnosis, and treatment options

Xiao Meng,Ming Song,Kai Zhang,Weida Lu,Yunyi Li,Cheng Zhang,Yun Zhang

DOI: https://doi.org/10.1002/mco2.631

2024-07-05

Abstract:Congenital heart disease (CHD) is a structural abnormality of the heart and/or great vessels and patients with CHD are at an increased risks of various morbidities throughout their lives and reduced long-term survival. Eventually, CHD may result in various complications including heart failure, arrhythmias, stroke, pneumonia, and sudden death. Unfortunately, the exact etiology and pathophysiology of some CHD remain unclear. Although the quality of life and prognosis of patients with CHD have significantly improved following technological advancement, the influence of CHD is lifelong, especially in patients with complicated CHD. Thus, the management of CHD remains a challenge due to its high prevalence. Finally, there are some disagreements on CHD among international guidelines. In this review, we provide an update of the pathophysiology, diagnosis, and treatment in most common type of CHD, including patent foramen ovale, atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent ductus arteriosus, coarctation of the aorta, transposition of the great arteries, congenitally corrected transposition of the great arteries, coronary anomalies, left and right ventricular outflow tract obstruction, tetralogy of Fallot and Ebstein anomaly. In particular, we focus on what is known and what is unknown in these areas, aiming to improve the current understanding of various types of CHD.
Delivery room and early postnatal management of neonates with congenital heart disease

Noorjahan Ali,Mary T. Donofrio

DOI: https://doi.org/10.1002/pd.6617

2024-06-12

Prenatal Diagnosis

Abstract:Advancements in prenatal detection have improved postnatal outcomes for patients with congenital heart disease (CHD). Detailed diagnosis during pregnancy allows for preparation for the delivery and immediate postnatal care for the newborns with CHD. Most CHDs do not result in hemodynamic instability at the time of birth and can be stabilized following the guidelines of the neonatal resuscitation program (NRP). Critical CHD that requires intervention immediately after birth is recommended to be delivered in facilities where immediate neonatal and cardiology care can be provided. Postnatal stabilization and resuscitation for these defects warrant deviation from the standardized NRP. For neonatal providers, knowing the diagnosis of fetal CHD allows for preparation for the anticipated instability in the delivery room. Prenatal detection fosters collaboration between fetal cardiology, cardiology specialists, obstetrics, and neonatology, improving outcomes for neonates with critical CHD.

genetics & heredity,obstetrics & gynecology
Pediatric Heart Surgery in China: Progress and Challenges

Xumin Mo,Di Yu,Qiang Shu

DOI: https://doi.org/10.1136/wjps-2019-000048

2019-01-01

World Journal of Pediatric Surgery

Abstract:Congenital heart disease (CHD) has become the most common birth defect and is now the first leading cause of infant mortality due to congenital malformations in China. According to the 2012 Birth Defects Report , CHD has been the first leading birth defect in China since a decade ago. Patients with CHD have reached 2 million in China, and newly diagnosed patients were estimated to be 150 000–2 00 000 annually.1 China has the largest population in the world and with 15% of all children worldwide. In 2016, there were 17.9 million newborns.2 After adoption of the universal two-child policy since 2015, the incidence of CHD may be increased as a result of high portion of women with high maternal age. Though with such high incidence of CHD and large population of patients with CHD, no country-level data registry has been established. Current epidemiology of CHD is regional and not accurate, lacking high evidence. According to the available data, we think that the incidence of CHD is varied across the country. The data of 2011 showed that incidence of CHD diagnosed during perinatal period is 6.8–14.39%. Some regional surveillance data showed that the prevalence of CHD was 3.81% in Jiuquan City from 2002 to 2003, 8.04% in Beijing City during 2007–2012, and 9.04% in Guangdong Province during 2006–2015.3 Concerning the disease types, ventricular septal defect, atrial septal defect, and patent ductus arteriosus account for 75%–80% of all CHD. The nationwide epidemiological study on CHD remains difficult in China because of no unified diagnosis techniques and guidelines among different regions, no standard surveillance in the migration population, and lacking knowledge of collecting big data for analysis in the population. A delightful news is that since 2018, the Chinese Government has launched national neonatal screening of congenital heart disease, …
Application of 3 D Printing Techniques in Treatment of Congenital Heart Disease

Jiajun Xu,Qiang Shu

DOI: https://doi.org/10.3785/j.issn.1008-9292.2019.10.17

2019-01-01

Abstract:Congenital heart disease (CHD) is the most common birth defect at present. In recent years, the application of 3D printing in the diagnosis and treatment of CHD has been widely recognized, which presents CHD lesions in 3D solid model and provides a better understanding of the anatomy of CHD. In the future, 3D printing technology would improve the surgical proficiency, shorten the operation time, reduce the occurrence of perioperative complications, and create more personalized cardiovascular implants, therefore promote the precision of diagnosis and treatment for congenital heart disease. This article reviews the application of 3D printing technology in preoperative planning, intraoperative navigation and personalized implants of CHD, in surgical training and medical education, as well as in promoting doctor-patient communication and better understanding their condition for patients.
Prenatal Diagnosis of Congenital Heart Disease: The Crucial Role of Perinatal and Delivery Planning

Sheetal R. Patel,Erik Michelfelder

DOI: https://doi.org/10.3390/jcdd11040108

2024-03-31

Journal of Cardiovascular Development and Disease

Abstract:Although most congenital heart defects (CHDs) are asymptomatic at birth, certain CHD lesions are at significant risk of severe hemodynamic instability and death if emergent cardiac interventions are not performed in a timely fashion. Therefore, accurate identification of at-risk fetuses and appropriate delivery resource planning according to the degree of anticipated hemodynamic instability is crucial. Fetal echocardiography has increased prenatal CHD detection in recent years due to advancements in ultrasound techniques and improved obstetrical cardiac screening protocols, enabling the prediction of newborns’ hemodynamic status. This assessment can guide multidisciplinary resource planning for postnatal care, including selection of delivery site, delivery room management, and transport to a cardiac center based on CHD risk severity. This review will discuss fetal cardiovascular physiology and the circulatory changes that occur at the time of and immediately following birth, outline fetal echocardiographic findings used to risk-stratify newborns with CHDs, and outline principles for neonatal resuscitation and initial transitional care in neonates with these complex CHD lesions.

cardiac & cardiovascular systems
Challenges in the Diagnosis of Adult Congenital Heart Diseases

Simina Crișan,Ruxandra-Maria Băghină,Silvia Luca,Oana Pătru,Mihai-Andrei Lazăr,Cristina Văcărescu,Marius Rus,Dragoș Cozma,Dan Gaiță,Constantin-Tudor Luca

DOI: https://doi.org/10.3390/jcm13164865

IF: 3.9

2024-08-19

Journal of Clinical Medicine

Abstract:Congenital heart diseases (CHD) are one of the most common birth defects and the main leading cause of death in children. Many patients with CHD are reaching adulthood due to the success of improved contemporary surgical procedures. Understanding the etiology of CHD remains important for patient clinical management. Both genetic and environmental factors are involved in the development and progression of CHD. Variations in many different genes and chromosomal anomalies can be associated with CHD, by expression of different mechanisms. Sporadic cases are the most frequently encountered in these patients. Atrial septal defect is a common congenital heart disease that refers to direct communication between atrial chambers, found isolated or associated with other syndromes. Imaging techniques, especially transthoracic and transesophageal echocardiography (TOE) represent the key for diagnosis and management of ASD. The disease has a major incidence in adulthood, due to late symptomatology, but assessment and treatment are important to avoid time-related complications. Ebstein's anomaly is a rare congenital disease, with a dominant genetic participation, characterized by an abnormal displacement of the tricuspid valve and right ventricular myopathy, often requiring surgical intervention. Alongside echocardiography, cardiac magnetic resonance (CMR) imaging is the gold standard tool for the assessment of ventricular volumes. Early diagnosis and adequate treatment are mandatory to avoid possible complications of CHD, and thus, ECG, as well as imaging techniques, are important diagnostic tools. However, patients with CHD need a special healthcare team for the entire monitorization in various life stages.

medicine, general & internal
Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China

Yingying Zhang,Jingyi Wang,Jianxin Zhao,Guoying Huang,Kaibo Liu,Wei Pan,Luming Sun,Jun Li,Wenli Xu,Chunhua He,Yunting Zhang,Shoujun Li,Hao Zhang,Jun Zhu,Yihua He

DOI: https://doi.org/10.1016/s2352-4642(23)00051-2

2023-06-10

The Lancet Child and Adolescent Health

Abstract:Summary Congenital heart disease (CHD), a wide spectrum of diseases with varied outcomes, is the most common congenital malformation worldwide. In this Series of three papers, we describe the burden of CHD in China; the development of screening, diagnosis, treatment, and follow-up strategies; and challenges associated with the disease. We also propose solutions and recommendations for policies and actions to improve the outcomes of CHD. In the first paper in this Series, we focus on prenatal and neonatal screening, diagnosis, and management of CHD. Based on advanced international knowledge, the Chinese Government has developed a network system comprising prenatal screening, diagnosis of CHD subtypes, specialist consultation appointments, and treatment centres for CHD. A new professional discipline, fetal cardiology, has been formed and rapidly developed. Consequently, the overall coverage of prenatal and neonatal screening and the accuracy of CHD diagnoses have gradually improved, and the neonatal CHD mortality rate has decreased substantially. However, China still faces several challenges in the prevention and treatment of CHD, such as insufficient diagnostic capabilities and unqualified consultation services in some regions and rural areas. Translation For the Chinese translation of the abstract see Supplementary Materials section.

pediatrics
[Specification for Genetic Diagnosis of Congenital Heart Disease].

Cardiovascular Medicine Professional Committee Of The Chinese Medical Education Association,Medical Genetics Branch Of Chinese Medical Association,Cardiology Group Of Pediatric Surgery Branch Of Chinese Medical Association,Guowei He,Ming Qi,Deye Yang

DOI: https://doi.org/10.3760/cma.j.cn511374-20230627-00396

2024-01-01

Abstract:Congenital heart disease (CHD) is one of the most common congenital malformations and a major cause of mortality among neonates and children. Conventional methods for the diagnosis of CHD have relied on clinical features and imaging findings. With the rapid development of genetic techniques, to identify the cause of CHD through genetic diagnosis has gained great significance for the early diagnosis, treatment, and prevention of CHD. However, currently there is still a lack of norms and standards for the genetic diagnosis of CHD. In view of this, experts from the relevant fields have formulated the present norm by integrating the latest research advances on CHD-related genes with the current clinical practice on the diagnosis and treatment of CHD and status quo of genetic diagnosis in China. The norm has been recommended by the Cardiology Section of the Chinese Medical Education Association, the Medical Genetics Branch and the Heart Group of Pediatric Surgery Branch of the Chinese Medical Association, which has formulated the procedures and norms of genetic testing, prenatal diagnosis, and genetic counseling for CHD, with an aim to provide reference for clinicians as the standards for the integrated diagnosis, early treatment, and prevention of CHD.
Conotruncal Heart Defects: A Narrative Review of Molecular Genetics, Genomics Research and Innovation

Sruthi Viswanathan,Prachi Sandeep Oza,Anikha Bellad,Anusha Uttarilli

DOI: https://doi.org/10.1089/omi.2024.0097

Abstract:Congenital heart defects (CHDs) are most prevalent cardiac defects that occur at birth, leading to significant neonatal mortality and morbidity, especially in the developing nations. Among the CHDs, conotruncal heart defects (CTDs) are particularly noteworthy, comprising a significant portion of congenital cardiac anomalies. While advances in imaging and surgical techniques have improved the diagnosis, prognosis, and management of CTDs, their molecular genetics and genomic substrates remain incompletely understood. This expert review covers the recent advances from January 2016 onward and examines the complexities surrounding the genetic etiologies, prevalence, embryology, diagnosis, and clinical management of CTDs. We also emphasize the known copy number variants and single nucleotide variants associated with CTDs, along with the current planetary health research efforts aimed at CTDs in large cohort studies. In all, this comprehensive narrative review of molecular genetics and genomics research and innovation on CTDs draws from and highlights selected works from around the world and offers new ideas for advances in CTD diagnosis, precision medicine interventions, and accurate assessment of prognosis and recurrence risks.
Study Progress of Diagnosis and Management of Arrhythmias Associated with Congenital Heart Disease in Children

Li Xiaomei

DOI: https://doi.org/10.3760/j.issn.2095-428x.2017.13.001

2017-01-01

Abstract:Congenital heart disease is a type of common birth defect and most can be cured by surgery with prominent prolongation of life expectancy.But,different kinds of arrhythmias accompanied by congenital heart disease,especially late onset postoperative arrhythmias have become one of the major causes of mortality in these patients.Management and effective treatment for fast and slow arrhythmias associated with congenital heart disease are quite critical.
The Management of Critical Congenital Heart Diseases in Neonates

HUANG Guo-ying

DOI: https://doi.org/10.3760/cma.j.issn.1673-4912.2011.04.001

2011-01-01

Abstract:The critical congenital heart diseases during the neonatal period include the following types: (1) congenital heart disease with ductus-dependent pulmonary blood supply:pulmonary atresia,critical pulmonary stenosis,tricuspid atresia, Ebstein anomaly. (2) Congenital heart disease with ductus-dependent systemic blood supply: hypoplastic left heart syndrome, interrupted aortic arch, critical aortic stenosis.(3) Other congenital heart disease:complete transposition of the great arteries,critical tetralogy of Fallot,total abnormal pulmonary venous drainage, and persistent trucus arteriosus. This article focuses on the management of these diseases.
Percutaneous closure of simple congenital heart diseases under echocardiographic guidance

Ying Jiang,Fanyan Luo,Haisong Bu

DOI: https://doi.org/10.1186/s40001-023-01398-8

2023-10-07

Abstract:Congenital heart disease (CHD), birth defect with the highest incidence rates worldwide, and is mainly characterized by the abnormal internal structure of the heart or/and the anatomical structure of great vessels. In the past few decades, CHD repair surgery through standard median sternotomy incision combined with cardiopulmonary bypass (CPB) technology has been considered the gold standard for surgical correction of heart and great vessels. With the promotion and clinical application of interventional catheterization technology, transcatheter closure of CHD under radioactive radiation has gradually been recognized and applied. However, its radiation exposure and potential complications related to arteriovenous vessels still face challenges. In recent years, an increasing number of surgeons have explored new surgical procedures, for the safe and effective treatment of CHD, as far as possible to reduce surgical trauma, avoid radiation exposure, and improve the cosmetic effect. Therefore, on the premise of satisfactory exposure or guidance, how to integrate ultrasound and percutaneous interventional technology remained the focus of the exploration. This mini-review highlights and summarizes the signs of progress of ultrasound intervention in the last decade that have proven the effectiveness and operability of a well-established procedure for percutaneous closure of congenital heart diseases under echocardiographic guidance only. We discuss potential diseases that will benefit from this emerging procedure based on this progress. Owing to the crucial advantages played by this strategy in the treatment of CHD, better understanding and promotion of this less exploited field may contribute to the development of therapeutics targeting CHD, improve medical utilization rate, promote the optimization of medical resources, and ultimately achieve precise and efficient medical treatment.
Fetal cardiology: changing the definition of critical heart disease in the newborn

M Słodki,M Respondek-Liberska,J D Pruetz,M T Donofrio

DOI: https://doi.org/10.1038/jp.2016.20

2016-03-10

Journal of Perinatology

Abstract:Infants born with congenital heart disease (CHD) may require emergent treatment in the newborn period. These infants are likely to benefit the most from a prenatal diagnosis, which allows for optimal perinatal planning. Several cardiac centers have created guidelines for the management of these high-risk patients with CHD. This paper will review and compare several prenatal CHD classification systems with a particular focus on the most critical forms of CHD in the fetus and newborn. A contemporary definition of critical CHD is one which requires urgent intervention in the first 24 h of life to prevent death. Such cardiac interventions may be not only life saving for the infant but also decrease subsequent morbidity. Critical CHD cases may require delivery at specialized centers that can provide perinatal, obstetric, cardiology and cardiothoracic surgery care. Fetuses diagnosed in mid-gestation require detailed fetal diagnostics and serial monitoring during the prenatal period, in order to assess for ongoing changes and identify progression to a more severe cardiac status. Critical CHD may progress in utero and there is still much to be learned about how to best predict those who will require urgent neonatal interventions. Despite improved therapeutic capabilities, newborns with critical CHD continue to have significant morbidity and mortality due to compromise that begins in the delivery room. Fetal echocardiography is the best way to predict the need for specialized care at birth to improve outcome. Once the diagnosis is made of critical CHD, delivery at the proper time and in appropriate institution with specific care protocols should be initiated. More work needs to be done to better delineate the risk factors for progression of critical CHD and to determine which newborns will require specialized care. The most frequently described forms of critical CHD requiring immediate intervention include hypoplastic left heart syndrome with intact or severely restricted atrial septum, obstructed total anomalous pulmonary venous return and transposition of the great arteries with restrictive atrial septum.

pediatrics,obstetrics & gynecology
Complex Congenital Heart Disease in the Adult

Sarah A. Goldstein,Richard A. Krasuski

DOI: https://doi.org/10.1146/annurev-med-050922-052324

2024-01-30

Annual Review of Medicine

Abstract:Congenital heart disease (CHD), a heterogeneous group of structural abnormalities of the cardiovascular system, is the most frequent cause of severe birth defects. Related to improved pediatric outcomes, there are now more adults living with CHD, including complex lesions, than children. Adults with CHD are at high risk for complications related to their underlying anatomy and past surgical palliative interventions. Adults with CHD require close monitoring and proactive management strategies to improve outcomes.

medicine, research & experimental
Congenital Cardiac Disease in the Newborn Infant: Past, Present, and Future

Sharyl L. Sadowski

DOI: https://doi.org/10.1016/j.ccell.2008.10.001

IF: 1.46

2009-03-01

Critical Care Nursing Clinics of North America

Abstract:Congenital heart defects are the most common of all congenital malformations, with a review of the literature reporting the incidence at 6 to 8 per 1000 live births. The Centers for Disease Control reports cyanotic heart defects occurred in 56.9 per 100,000 live births in the United States in 2005, with higher rates noted when maternal age exceeded 40 years. The incidence of congenital heart disease in premature infants is 12.5 per 1000 live births, excluding isolated patent ductus arteriosus and atrial septal defect. Despite advances in detection and treatment, congenital heart disease accounts for 3% of all infant deaths and 46% of death from congenital malformations. This article discusses the embryology, pathogenesis, clinical presentation, incidence, classifications, and management of congenital heart diseases.

nursing
Advancement in Research on Genes Associated with Fetal Congenital Heart Disease(chd)and Diagnostic Testing Methods

Junshu Xie,Kexin Zhang,Xiaohong Zhang

DOI: https://doi.org/10.1016/j.gocm.2023.04.005

2023-01-01

Gynecology and Obstetrics Clinical Medicine

Abstract:Introduction:Congenital heart disease(CHD)is one of the most common congenital malformations,and is a polygenic disease related to some major genes and involved in environmental factors.With the progress of science and technology,the progress was both in the studies of genetic patterns and testing methods.Understanding how each gene participates in normal and pathological anatomy is an important goal of CHD research.We reviewed the development of testing methods and CHD-related genes,to provide some enlightenment for the CHD prenatal diagnosis and hope to realize the intervention and treatment on the gene level of CHD in the future.

Recent Advances in the Diagnosis and Management of Congenital Heart Disease

The Progress and Challenges of Surgical Treatment for Congenital Heart Disease

ADVANCES IN DIAGNOSIS AND TREATMENT OF CONGENITAL HEART DISEASE: A COMPREHENSIVE REVIEW

The Current Strategy in Managing Congenital and Structural Heart Disease: Find and Treat Them Appropriately

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Congenital heart disease: types, pathophysiology, diagnosis, and treatment options

Delivery room and early postnatal management of neonates with congenital heart disease

Pediatric Heart Surgery in China: Progress and Challenges

Application of 3 D Printing Techniques in Treatment of Congenital Heart Disease

Prenatal Diagnosis of Congenital Heart Disease: The Crucial Role of Perinatal and Delivery Planning

Challenges in the Diagnosis of Adult Congenital Heart Diseases

Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China

[Specification for Genetic Diagnosis of Congenital Heart Disease].

Conotruncal Heart Defects: A Narrative Review of Molecular Genetics, Genomics Research and Innovation

Study Progress of Diagnosis and Management of Arrhythmias Associated with Congenital Heart Disease in Children

The Management of Critical Congenital Heart Diseases in Neonates

Percutaneous closure of simple congenital heart diseases under echocardiographic guidance

Fetal cardiology: changing the definition of critical heart disease in the newborn

Complex Congenital Heart Disease in the Adult

Congenital Cardiac Disease in the Newborn Infant: Past, Present, and Future

Advancement in Research on Genes Associated with Fetal Congenital Heart Disease(chd)and Diagnostic Testing Methods